Gluskin Sheff & Assoc Inc Abb Vie Inc. Transaction History
Gluskin Sheff & Assoc Inc
- $797 Million
- Q4 2024
A detailed history of Gluskin Sheff & Assoc Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 15,192 shares of ABBV stock, worth $3.25 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
15,192
Previous 15,282
0.59%
Holding current value
$3.25 Million
Previous $3.02 Million
10.54%
% of portfolio
0.34%
Previous 0.37%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
4,108Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$37 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$17 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.49 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $378B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...